During the past decade, Daugavpils Regional Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 15 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Daugavpils Regional Hospital" #1 sponsor was "Bayer" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Anthos Therapeutics, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Daugavpils Regional Hospital" #1 collaborator was "Itreas" with 2 trials as a collaborator, "Cosmo Technologies Ltd" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Daugavpils Regional Hospital" are "Heart Failure" (3 trials), "Venous Thromboembolism" (3 trials), "Arthritis, Psoriatic" (2 trials), "Atrial Fibrillation" (2 trials) and "Deep Venous Thrombosis" (2 trials). Many other conditions were trialed in "Daugavpils Regional Hospital" in a lesser frequency.

Most popular intervention types in "Daugavpils Regional Hospital" are "Drug" (29 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Apixaban" (3 trials), "Abelacimab" (2 trials), "Apixaban matching placebo" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Daugavpils Regional Hospital" are 27 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Daugavpils Regional Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Daugavpils Regional Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Daugavpils Regional Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".